The vaccine-induced rally continues - Tuesday Review, November 24

The vaccine-induced rally continues - Tuesday Review, November 24

The global markets rebound as Biden’s transition lifts investors hope

The US

The progress reported by the pharma companies to deliver a COVID-19 vaccine caused the benchmarks to close in the green. The fact that Trump finally agreed with the transition of power at the White House added momentum. USA30 went up 1.54%, reaching its highest level since March. USA500 added 1.62%, while TECH100 inched up 1.31%.

Crude Oil closed 1.5% higher at $43.69 a barrel.

Gold settled at $1,804.60 per ounce after it lost 1.8%.

The Dollar Index traded at 92.235.

Asia and Australia

The benchmarks edged higher as President-elect Joe Biden received the formal go-ahead to begin his transition to the White House. Gains in the energy, real estate, and financial sectors contributed to the surge.

Japan225 surged 2.5%, reaching its highest level since May 1991.

HongKong45 went up 0.6%.

Down under, Australia200 closed 1.26% higher.

Europe

The markets ended higher as they are enthusiastic about the progress towards a viable COVID-19 vaccine. Also, one of the largest European economies posted a GDP rebound in Q3. Germany30 and UK100 each traded 0.6% higher. France40 rose 0.9%.

Brent Oil gained 1.1% to $46.57 per barrel.

EUR/USD closed at 1.1877 after it went up 0.3%.

Sources: reuters.com, investing.com

The information presented herein is prepared by CAPEX.com and does not intend to constitute Investment Advice. The information herein is provided as a general marketing communication for information purposes only and as such it has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and it is not subject to any prohibition on dealing ahead of the dissemination of investment research.

Users/readers should not rely solely on the information presented herewith and should do their own research/analysis by also reading the actual underlying research. The content herewith is generic and does not take into consideration individual personal circumstances, investment experience or current financial situation.

Therefore, Key Way Investments Ltd shall not accept any responsibility for any losses of traders due to the use and the content of the information presented herein. Past performance is not a reliable indicator of future results.